REPORT ID 1545

EMEA (Europe, Middle East and Africa) Anaesthetic Drugs and Pain Drugs Market Report 2017

Publish Date
06-Dec-17
Pages
101
Format
Electronic (PDF)

In this report, the EMEA Anaesthetic Drugs and Pain Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Anaesthetic Drugs and Pain Drugs for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anaesthetic Drugs and Pain Drugs market competition by top manufacturers/players, with Anaesthetic Drugs and Pain Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca
    Endo International
    Johnson & Johnson
    Pfizer
    Purdue Pharma
    Baxter
    Bayer AG
    Merck
    Novartis

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Anaesthetic Drugs
    Pain Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Anaesthetic Drugs and Pain Drugs Market Report 2017
1 Anaesthetic Drugs and Pain Drugs Overview
    1.1 Product Overview and Scope of Anaesthetic Drugs and Pain Drugs
    1.2 Classification of Anaesthetic Drugs and Pain Drugs
        1.2.1 EMEA Anaesthetic Drugs and Pain Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Anaesthetic Drugs and Pain Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Anaesthetic Drugs
        1.2.4 Pain Drugs
    1.3 EMEA Anaesthetic Drugs and Pain Drugs Market by Application/End Users
        1.3.1 EMEA Anaesthetic Drugs and Pain Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 EMEA Anaesthetic Drugs and Pain Drugs Market by Region
        1.4.1 EMEA Anaesthetic Drugs and Pain Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Anaesthetic Drugs and Pain Drugs (2012-2022)
        1.5.1 EMEA Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Anaesthetic Drugs and Pain Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Anaesthetic Drugs and Pain Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Anaesthetic Drugs and Pain Drugs Market Competition by Players/Manufacturers
        2.1.1 EMEA Anaesthetic Drugs and Pain Drugs Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Anaesthetic Drugs and Pain Drugs Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Anaesthetic Drugs and Pain Drugs Sale Price by Players (2012-2017)
    2.2 EMEA Anaesthetic Drugs and Pain Drugs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Anaesthetic Drugs and Pain Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Anaesthetic Drugs and Pain Drugs Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Anaesthetic Drugs and Pain Drugs Sale Price by Type (2012-2017)
    2.3 EMEA Anaesthetic Drugs and Pain Drugs (Volume) by Application
    2.4 EMEA Anaesthetic Drugs and Pain Drugs (Volume and Value) by Region
        2.4.1 EMEA Anaesthetic Drugs and Pain Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Anaesthetic Drugs and Pain Drugs Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Anaesthetic Drugs and Pain Drugs Sales Price by Region (2012-2017)

3 Europe Anaesthetic Drugs and Pain Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Anaesthetic Drugs and Pain Drugs Sales and Value (2012-2017)
        3.1.1 Europe Anaesthetic Drugs and Pain Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Anaesthetic Drugs and Pain Drugs Revenue and Growth Rate (2012-2017)
    3.2 Europe Anaesthetic Drugs and Pain Drugs Sales and Market Share by Type
    3.3 Europe Anaesthetic Drugs and Pain Drugs Sales and Market Share by Application
    3.4 Europe Anaesthetic Drugs and Pain Drugs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Anaesthetic Drugs and Pain Drugs Sales Volume by Countries (2012-2017)
        3.4.2 Europe Anaesthetic Drugs and Pain Drugs Revenue by Countries (2012-2017)
        3.4.3 Germany Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)
        3.4.4 France Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)
        3.4.5 UK Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)
        3.4.6 Russia Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)
        3.4.7 Italy Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)

4 Middle East Anaesthetic Drugs and Pain Drugs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Anaesthetic Drugs and Pain Drugs Sales and Value (2012-2017)
        4.1.1 Middle East Anaesthetic Drugs and Pain Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Anaesthetic Drugs and Pain Drugs Revenue and Growth Rate (2012-2017)
    4.2 Middle East Anaesthetic Drugs and Pain Drugs Sales and Market Share by Type
    4.3 Middle East Anaesthetic Drugs and Pain Drugs Sales and Market Share by Application
    4.4 Middle East Anaesthetic Drugs and Pain Drugs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Anaesthetic Drugs and Pain Drugs Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Anaesthetic Drugs and Pain Drugs Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)
        4.4.4 Israel Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)
        4.4.5 UAE Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)
        4.4.6 Iran Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)

5 Africa Anaesthetic Drugs and Pain Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Anaesthetic Drugs and Pain Drugs Sales and Value (2012-2017)
        5.1.1 Africa Anaesthetic Drugs and Pain Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Anaesthetic Drugs and Pain Drugs Revenue and Growth Rate (2012-2017)
    5.2 Africa Anaesthetic Drugs and Pain Drugs Sales and Market Share by Type
    5.3 Africa Anaesthetic Drugs and Pain Drugs Sales and Market Share by Application
    5.4 Africa Anaesthetic Drugs and Pain Drugs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Anaesthetic Drugs and Pain Drugs Sales Volume by Countries (2012-2017)
        5.4.2 Africa Anaesthetic Drugs and Pain Drugs Revenue by Countries (2012-2017)
        5.4.3 South Africa Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Anaesthetic Drugs and Pain Drugs Sales and Growth Rate (2012-2017)

6 EMEA Anaesthetic Drugs and Pain Drugs Manufacturers/Players Profiles and Sales Data
    6.1 AstraZeneca
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Anaesthetic Drugs and Pain Drugs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AstraZeneca Anaesthetic Drugs and Pain Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Endo International
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Anaesthetic Drugs and Pain Drugs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Endo International Anaesthetic Drugs and Pain Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Johnson & Johnson
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Anaesthetic Drugs and Pain Drugs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Johnson & Johnson Anaesthetic Drugs and Pain Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Anaesthetic Drugs and Pain Drugs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Anaesthetic Drugs and Pain Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Purdue Pharma
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Anaesthetic Drugs and Pain Drugs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Purdue Pharma Anaesthetic Drugs and Pain Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Baxter
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Anaesthetic Drugs and Pain Drugs Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Baxter Anaesthetic Drugs and Pain Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Bayer AG
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Anaesthetic Drugs and Pain Drugs Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Bayer AG Anaesthetic Drugs and Pain Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Merck
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Anaesthetic Drugs and Pain Drugs Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Merck Anaesthetic Drugs and Pain Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Novartis
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Anaesthetic Drugs and Pain Drugs Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Novartis Anaesthetic Drugs and Pain Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Anaesthetic Drugs and Pain Drugs Manufacturing Cost Analysis
    7.1 Anaesthetic Drugs and Pain Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Anaesthetic Drugs and Pain Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Anaesthetic Drugs and Pain Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Anaesthetic Drugs and Pain Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Anaesthetic Drugs and Pain Drugs Market Forecast (2017-2022)
    11.1 EMEA Anaesthetic Drugs and Pain Drugs Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Anaesthetic Drugs and Pain Drugs Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Anaesthetic Drugs and Pain Drugs Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Anaesthetic Drugs and Pain Drugs Price and Trend Forecast (2017-2022)
    11.2 EMEA Anaesthetic Drugs and Pain Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Anaesthetic Drugs and Pain Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Anaesthetic Drugs and Pain Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Anaesthetic Drugs and Pain Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Anaesthetic Drugs and Pain Drugs Sales Forecast by Type (2017-2022)
    11.7 EMEA Anaesthetic Drugs and Pain Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer